Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-086135
Filing Date
2025-06-13
Accepted
2025-06-13 16:04:26
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5920
  Complete submission text file 0000950170-25-086135.txt   7467
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SOLENO THERAPEUTICS INC. 1235 RADIO ROAD, SUITE 110 REDWOOD CITY CA 94065
Business Address
Sinclair Andrew (Reporting) CIK: 0001762451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 251046402